Shares in AbbVie slumped Monday after the company disclosed its psychiatric medicine emraclidine didn’t best placebo in two ...

The pair had exploited the vulnerable occupant of the address, in order to use his home as a base to deal drugs from – often called Cuckooing. Parkinson was jailed for 37 months for the offences, ...

Annovis Bio (NYSE: ANVS) provided a third-quarter update, announcing significant progress in developing its lead drug candidate, buntanetap, for Alzheimer’s disease (“AD”) a ...

AbbVie said its recently acquired emraclidine drug candidate for schizophrenia missed the key goal in a pair of mid-stage studies, sending the biopharmaceutical company's shares down more than 10% in ...

There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.

Baby-faced Jack Parkinson, 18, and his pal Luke Derby, 19, were caught out after a concerned call from a member of the public ...

Nilotinib, a blood cancer medicine, was previously shown to improve movement and mental function in a small group of patients ...

The following column was originally published on Feb. 25, 2022. Thanks to breakthroughs in medicine and nutrition in recent years, we are living longer than ever before. But this increase in life ...

Zizyphi spinosi semen demonstrates neuroprotective effects, improving cognitive function and reducing amyloid and tau pathology in models of aging and dementia.

Specialty net revenue increased 19% to $115.64 million, driven by promoted products in neurology and endocrinology, including ...